AGP Picks
View all

Cholestatic pruritus market forecast to reach $25.99 billion by 2030

18 hours ago
Cholestatic pruritus market forecast to reach $25.99 billion by 2030
By AI, Created 19:15 UTC, Nov 18, 2026, AGP -

The cholestatic pruritus market is projected to grow from $20.22 billion in 2025 to $25.99 billion by 2030, driven by rising liver disease cases, new therapies and broader diagnosis. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Cholestatic pruritus is a severe itching condition tied to impaired bile flow in liver disease, and it can sharply reduce quality of life. - Rising demand for better symptom control is pushing development of new treatments beyond standard antihistamine therapy. - The market’s growth reflects a larger increase in liver disease burden and specialist care needs.

What happened: - The Business Research Company said the global cholestatic pruritus market is projected to grow 5.1% annually to $25.99 billion by 2030. - The market is expected to rise from $20.22 billion in 2025 to $21.3 billion in 2026, a 5.3% CAGR over that period. - The outlook appears in The Business Research Company’s Cholestatic Pruritus Global Market Report 2026. - The report also offers a free sample.

The details: - The report links market growth to rising chronic liver disease cases, limited results from conventional antihistamines, more hepatology specialization, more frequent diagnosis of cholestatic conditions and wider access to supportive therapies. - The forecast is supported by expected novel therapeutic approvals, greater investment in rare disease research, liver disease-specific targeted drugs and more personalized treatment strategies. - Key product trends include anti-pruritic drugs tailored to symptoms, symptom-specific management, greater use of oral bile acid modulators, expanded liver disease research and more patient-centered care. - Cholestatic pruritus is caused by bile acid buildup in the skin from liver diseases that disrupt normal bile flow. - The condition often requires specialized treatment aimed at both itch relief and the underlying liver disorder. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market opportunity is being shaped less by symptom prevalence alone and more by the lack of effective legacy treatments. - A stronger focus on rare disease research suggests drug developers see cholestatic pruritus as a niche with room for targeted innovation. - The regional split points to mature demand in North America and faster adoption potential in markets where diagnosis and access are still expanding. - UK hospital data cited in the report showed 85,665 liver disease admissions in England in 2023, underscoring the patient base behind the forecast.

What's next: - The report expects continued uptake of personalized treatments and liver disease-targeted drugs through 2030. - Market growth will likely track progress in diagnosis, specialist care and regulatory approvals for new therapies. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards and market hotspot infographics.

The bottom line: - The cholestatic pruritus market is moving from a symptom-management niche into a broader drug-development opportunity as liver disease diagnoses rise and new therapies enter the pipeline.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.